000			01236 a2200349 4500
005			20250514041615.0
264		0	_c20020913
008			200209s 0 0 eng d
022			_a0250-7005
040			_aNLM _beng _cNLM
100	1		_aGao, Z O
245	0	0	_aDevelopment of cross-resistance to tamoxifen in raloxifene-treated breast carcinoma cells. _h[electronic resource]
260			_bAnticancer research _c
300			_a1379-83 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents, Hormonal _xpharmacology
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Division _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Resistance, Multiple
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aRaloxifene Hydrochloride _xpharmacology
650	0	4	_aSelective Estrogen Receptor Modulators _xpharmacology
650	0	4	_aTamoxifen _xpharmacology
650	0	4	_aTumor Cells, Cultured
700	1		_aGao, Z P
700	1		_aFields, J Z
700	1		_aBoman, B M
773	0		_tAnticancer research _gvol. 22 _gno. 3 _gp. 1379-83
999			_c12051716 _d12051716